<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">We shall code medicinal products to substance level, using the WHO Drug Dictionaries (WHO-DD, latest version available at the start of the review), and, where possible, code adverse events at the Low-Level Term level of the hierarchy in the Medical Dictionary for Regulatory Activities® (MedDRA) (latest version available at the start of the review), (e.g. “increased mortality” and seriousness of adverse events cannot be coded in MedDRA).</p>
